← Open Payments lookup

JOANN PAOLETTI: Open Payments

NPI 1164969226 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,911 in 104 payments from 12 companies in 2025. Trend: 2023 $1,659 · 2024 $2,149 · 2025 $1,911

Food & beverage: $1,881Education: $31
CompanyPaymentsAmount
ABBVIE INC.28$468
Vanda Pharmaceuticals Inc.25$315
Alkermes, Inc.15$285
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$273
Otsuka America Pharmaceutical, Inc.8$247
E.R. Squibb & Sons, L.L.C.5$92
Lundbeck LLC4$80
Supernus Pharmaceuticals, Inc.3$44
Biogen, Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.2$35

Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, ARISTADA, COBENFY, LYBALVI, Qelbree.

Industry payments across NY — which companies pay providers there.